X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males
- PMID: 10752524
- DOI: 10.1681/ASN.V114649
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males
Abstract
Alport syndrome (AS) is a type IV collagen hereditary disease characterized by the association of progressive hematuric nephritis, hearing loss, and, frequently, ocular changes. Mutations in the COL4A5 collagen gene are responsible for the more common X-linked dominant form of the disease. Considerable allelic heterogeneity has been observed. A "European Community Alport Syndrome Concerted Action" has been established to delineate accurately the AS phenotype and to determine genotype-phenotype correlations in a large number of families. Data concerning 329 families, 250 of them with an X-linked transmission, were collected. Characteristics of the 401 male patients belonging to the 195 families with COL4A5 mutation are presented. All male patients were hematuric, and the rate of progression to end-stage renal failure and deafness was mutation-dependent. Large deletions, non-sense mutations, or small mutations changing the reading frame conferred to affected male patients a 90% probability of developing end-stage renal failure before 30 yr of age, whereas the same risk was of 50 and 70%, respectively, in patients with missense or splice site mutation. The risk of developing hearing loss before 30 yr of age was approximately 60% in patients with missense mutations, contrary to 90% for the other types of mutations. The natural history of X-linked AS and correlations with COL4A5 mutations have been established in a large cohort of male patients. These data could be used for further evaluation of therapeutic approaches.
Similar articles
-
X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study.J Am Soc Nephrol. 2003 Oct;14(10):2603-10. doi: 10.1097/01.asn.0000090034.71205.74. J Am Soc Nephrol. 2003. PMID: 14514738
-
Alport syndrome. Molecular genetic aspects.Dan Med Bull. 2009 Aug;56(3):105-52. Dan Med Bull. 2009. PMID: 19728970
-
Alport syndrome. A review of the ocular manifestations.Ophthalmic Genet. 1997 Dec;18(4):161-73. doi: 10.3109/13816819709041431. Ophthalmic Genet. 1997. PMID: 9457747 Review.
-
[Molecular genetics of Alport syndrome].Nihon Rinsho. 1992 Dec;50(12):3021-6. Nihon Rinsho. 1992. PMID: 1491454 Review. Japanese.
-
Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling.Nephrol Dial Transplant. 2002 Jul;17(7):1218-27. doi: 10.1093/ndt/17.7.1218. Nephrol Dial Transplant. 2002. PMID: 12105244
Cited by
-
Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.Am J Physiol Renal Physiol. 2021 Jul 1;321(1):F12-F25. doi: 10.1152/ajprenal.00035.2021. Epub 2021 May 24. Am J Physiol Renal Physiol. 2021. PMID: 34029143 Free PMC article.
-
Pathogenesis of glomerular haematuria.World J Nephrol. 2015 May 6;4(2):185-95. doi: 10.5527/wjn.v4.i2.185. World J Nephrol. 2015. PMID: 25949932 Free PMC article. Review.
-
Alport Syndrome: A Comprehensive Review.Cureus. 2023 Oct 16;15(10):e47129. doi: 10.7759/cureus.47129. eCollection 2023 Oct. Cureus. 2023. PMID: 38021591 Free PMC article. Review.
-
Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review.Pediatr Nephrol. 2016 Apr;31(4):523-33. doi: 10.1007/s00467-015-3119-1. Epub 2015 May 17. Pediatr Nephrol. 2016. PMID: 25980470 Review.
-
A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome.PLoS One. 2015 Jul 13;10(7):e0132010. doi: 10.1371/journal.pone.0132010. eCollection 2015. PLoS One. 2015. PMID: 26168235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials